Sino Biopharmaceutical to adopt new articles of association

Sino Biopharmaceutical Limited announced its board of directors' proposal to adopt new articles of association to align with recent amendments to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, specifically concerning the expansion of paperless listing and treasury shares regimes. These changes include incorporating amendments to the existing articles of association and encompass other housekeeping updates for clarity and consequential reasons. The adoption is subject to shareholder approval via a special resolution at the forthcoming annual general meeting. Details of the proposed amendments will be dispatched to shareholders. The announcement was made by Chairwoman Tse, Theresa Y Y on April 23, 2025.